EXENT CORP. Balance Sheet | Understand Stock

Ask AI

Financial Statements

In USD, except per-share amounts

	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018
ASSETS
Current Assets
Cash
Accounts Receivables
Inventory, Net
Prepaid expenses
Total Current Assets
Property, Plant and Equipment, Gross
Property and equipment, net of accumulated depreciation
Total Non-current Assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Loan from related parties
Accounts Payable
Loans Payable, Current
Total Liabilities

Accounts Payable and Accrued Liabilities, Noncurrent
Due to Related Parties, Noncurrent
Total Liabilities
Commitments and Contingencies
Stockholders’ Deficit
Common stock, $0.001 par value, 75,000,000 shares authorized; 2,027,000 and 2,027,000 shares issued and outstanding as of September 30, 2019 and December 31, 2018 respectively
Common Stock, Shares Outstanding
Common stock, $0.001 par value, 75,000,000 shares authorized; 2,027,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020
Additional Paid in Capital, Common Stock
Additional paid-in-capital
Accumulated Deficit
Common Stock, Shares Authorized
Total Stockholders’ Equity (Deficit)
Total Liabilities and Stockholders’ Equity

Comments